about
Guidelines for the use and interpretation of assays for monitoring autophagyCross-talk between the proto-oncogenes Met and RonRab4b is a small GTPase involved in the control of the glucose transporter GLUT4 localization in adipocyteEnigma interacts with adaptor protein with PH and SH2 domains to control insulin-induced actin cytoskeleton remodeling and glucose transporter 4 translocationCompounds Triggering ER Stress Exert Anti-Melanoma Effects and Overcome BRAF Inhibitor ResistanceSustained recruitment of phospholipase C-gamma to Gab1 is required for HGF-induced branching tubulogenesisHyperosmotic stress inhibits insulin receptor substrate-1 function by distinct mechanisms in 3T3-L1 adipocytesGab1 phosphorylation: a novel mechanism for negative regulation of HGF receptor signalingPositive and negative regulation of insulin signaling through IRS-1 phosphorylationIncreased adipose tissue expression of hepcidin in severe obesity is independent from diabetes and NASHInteraction of Janus kinases JAK-1 and JAK-2 with the insulin receptor and the insulin-like growth factor-1 receptorMAP kinases and mTOR mediate insulin-induced phosphorylation of insulin receptor substrate-1 on serine residues 307, 612 and 632The osteopontin level in liver, adipose tissue and serum is correlated with fibrosis in patients with alcoholic liver diseaseHepatic expression patterns of inflammatory and immune response genes associated with obesity and NASH in morbidly obese patientsCannabinoid CB2 receptor potentiates obesity-associated inflammation, insulin resistance and hepatic steatosisTpl2 kinase is upregulated in adipose tissue in obesity and may mediate interleukin-1beta and tumor necrosis factor-{alpha} effects on extracellular signal-regulated kinase activation and lipolysis.Metabolism dysregulation induces a specific lipid signature of nonalcoholic steatohepatitis in patientsLow Levels of 25-Hydroxy Vitamin D are Independently Associated with the Risk of Bacterial Infection in Cirrhotic Patients.Osteopontin deficiency aggravates hepatic injury induced by ischemia-reperfusion in miceLiquid chromatography-mass spectrometry-based parallel metabolic profiling of human and mouse model serum reveals putative biomarkers associated with the progression of nonalcoholic fatty liver disease.Autophagy and non-alcoholic fatty liver disease.Hematopoietic IKBKE limits the chronicity of inflammasome priming and metaflammation.Positive and negative regulation of glucose uptake by hyperosmotic stress.Defects in mitophagy promote redox-driven metabolic syndrome in the absence of TP53INP1Alteration in insulin action: role of IRS-1 serine phosphorylation in the retroregulation of insulin signalling.Obesity-dependent metabolic signatures associated with nonalcoholic fatty liver disease progressionIdentification of adipose tissue dendritic cells correlated with obesity-associated insulin-resistance and inducing Th17 responses in mice and patientsER stress induces NLRP3 inflammasome activation and hepatocyte death.Elevated expression of osteopontin may be related to adipose tissue macrophage accumulation and liver steatosis in morbid obesityRoux-En Y Gastric Bypass Results in Long-Term Remission of Hepatocyte Apoptosis and Hepatic Histological Features of Non-alcoholic Steatohepatitis.Autophagy, signaling and obesity.Non-alcoholic steatohepatitis in morbidly obese patients.Involvement of TNF-alpha in abnormal adipocyte and muscle sortilin expression in obese mice and humans.CD44 is a key player in non-alcoholic steatohepatitis.Autophagy in chronic liver diseases: the two faces of Janus.Determinants associated with the correction of glomerular hyper-filtration one year after bariatric surgery.Severe Vitamin D Deficiency Is Not Associated with Liver Damage in Morbidly Obese Patients.Hepatocyte growth factor induces glucose uptake in 3T3-L1 adipocytes through A Gab1/phosphatidylinositol 3-kinase/Glut4 pathway.Differential effects of IRS1 phosphorylated on Ser307 or Ser632 in the induction of insulin resistance by oxidative stress.Immunoglobulin G4-associated autoimmune hepatitis may be found in Western countries.
P50
Q21996341-E1D90379-A304-45A5-8E67-01C84A31D9ECQ22254408-84CC9F71-9669-4F5E-ADC2-A67562396510Q24312899-0116C69F-F854-4942-AC18-8CAB2334D110Q24672214-5493EE9E-9744-4915-9242-A9BD4BEC6033Q28115258-50C4C36B-4FAF-4EA0-9B85-6CAA44A8BC10Q28139783-89454FDE-2CEB-433A-87A7-AD470F1E3EC0Q28202364-8F0152B8-A9B0-4300-AEC0-852D6DA3763EQ28213808-7429BA76-3469-453B-942A-7C9B7130932EQ28236905-78B9591B-01BD-4BB7-8A32-F04EE22518E6Q28261861-1DFF6C03-36B8-4639-B734-944CE693A7F3Q28264007-011A8633-F476-4575-B4F3-9CB23F1F742EQ28508130-E4905483-E989-4598-AA81-E0264705843DQ28730527-087E0B3B-1BFA-4DFA-85FB-9A46FF273CFEQ28748743-77140B6E-63CF-4953-AD3C-2468BCEAD847Q33464957-EB03AC01-7EA4-4FB6-A604-4A29496E1973Q33556670-16B60D76-BF89-44A0-B4F6-46321DBD78B3Q33594722-6676380C-98C8-4A9E-8428-E39A257C6981Q33701184-9ABDC815-1513-4445-A604-0F92D1B738BDQ33720224-9F27488D-70B0-4D08-BADD-9AC9055AE431Q34103693-AEFFC858-23D7-48E1-A296-4D97F345CC61Q34247340-CA284C1B-0E65-4D4D-9E4A-69A253C13EE0Q34985696-6E14CD95-0541-4F25-A646-48E6046BAF56Q35621281-4A0C521A-2790-4B35-A1AC-268345F0DC96Q35695391-5193ABE9-D0C2-48FC-8498-5CC5312D2E73Q35762318-C5894B1B-71E9-4B58-BD4B-46A2742311F6Q35874842-F837ADA4-2B3C-4352-B9DA-36F324F2270CQ36182516-46914667-DFC0-457B-8790-469446AD09A5Q36293033-C6C5AC1D-245B-4F7F-B6C9-777FC115C1ECQ37023005-A1C07C59-65A7-448F-837E-12DF02E2766BQ37188048-E266613E-07C6-4A79-9E33-9FB5BA00E9B2Q38043856-26394012-D255-43B4-B09A-8F8FF1B4EBBBQ38076567-5C9A6BE3-861A-4B33-9F75-06774F835AEBQ38356608-C57E5E81-93A0-4375-913B-790037476F71Q38890869-7CEE9F47-F272-4B21-ACB3-405CB1824BB5Q39024897-0891C2CF-2290-4769-BB4A-6B9642BEC22DQ40059251-F9D2509F-2CD8-48D1-A514-F80628BDEFDFQ40086139-F328A288-6ECE-43F1-B1EF-E05058FBD2CAQ40173924-22A378CD-6F99-4517-A279-95CC4EB0ED9CQ40245739-8A500088-3B37-4A30-94CD-1A544BF889DDQ41136977-6BA0B675-0829-4966-A08B-636B41E574A4
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
Philippe Gual
@ast
Philippe Gual
@en
Philippe Gual
@es
Philippe Gual
@nl
Philippe Gual
@sl
type
label
Philippe Gual
@ast
Philippe Gual
@en
Philippe Gual
@es
Philippe Gual
@nl
Philippe Gual
@sl
prefLabel
Philippe Gual
@ast
Philippe Gual
@en
Philippe Gual
@es
Philippe Gual
@nl
Philippe Gual
@sl
P214
P106
P1153
6701832829
P21
P213
0000 0001 4009 3000
P214
P31
P496
0000-0001-7393-8356
P735
P7859
viaf-210309544